US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Anti-Pandemic Concept

1,811.11

-13.8750-0.76%

Number of Gainers:8

Number of Losers:10

Number of Flat:1

PE:- -

High:1,831.56

Open:1,825.61

Low:1,802.81

Close:1,824.99

Volume:90.97M

Turnover:8.22B

Market Cap:1.47T

Float Cap:1.44T

Loading ...

Analysts Offer Insights on Healthcare Companies: Inventiva (IVA) and Moderna (MRNA)

Judge Rejects Pfizer, BioNTech, and Moderna Bid to Dismiss Monsanto mRNA Patent Lawsuit

How Investors May Respond To Pfizer (PFE) ESMO Cancer Data Showcase

Simply Wall St.

Hutchmed says AstraZeneca submits NDA for ORPATHYS+TAGRISSO in NSCLC

Stocks to Watch: Summit Therapeutics, Sangoma, Navitas

Nanoviricides Q4 EPS $(0.10), Inline

Benzinga Earnings

Summit Therapeutics, AstraZeneca enter clinical collaboration agreement

Novavax Inc. Stock Outperforms Competitors on Strong Trading Day

BioNTech CEO Uğur Şahin Disposes of USD 6,090,748 in Common Shares

NanoViricides FY26 Net Loss Narrows 13% to $8.22 Million; Revenue Remains no Revenue

Pfizer, Moderna Lose Bids to Escape Bayer US mRNA Patent Lawsuit

Market Chatter: BioNTech to Close 3 German Sites After Unsuccessful Sale Efforts

MT Newswires Live

AstraZeneca Advances Fixed-Dose Cholesterol Combo With Completed Phase I Bioavailability Study

AstraZeneca PLC Stock Rises Monday, Outperforms Market

Pfizer's Tilrekimig Phase 3 Program Seen as Potential Upside Driver, UBS Says

MT Newswires Live

BioNTech to Proceed with Site Closures After Failing to Find Buyer

US Drugmakers Turn to China for Licensing Deals

NanoViricides Starts Phase II DRC Trial of Oral NV-387 Gummies in Bundibugyo Ebola Patients

Humacyte Adds Scott Coward to Board, Names Him to Audit Committee

Xilio Therapeutics Names Yariv Houvras Chief Medical Officer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/BK4568/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1811.1105,"timestamp":1790971199999,"preClose":1824.9855,"halted":0,"volume":90970843,"delay":0,"changeRate":-0.007603,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-13.875,"latestTime":"10-02 16:00:00 EDT","open":1825.6097,"high":1831.557,"low":1802.8068,"amount":8217801901.581731,"amplitude":0.015754,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.847322,"peRate":47.020292,"turnoverRate":0.006557,"increases":8,"decrements":10,"flats":1,"marketCap":1472930542925.5,"floatMarketCap":1437881726786},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1831.557,"amplitude":0.015754,"preClose":1824.9855,"low":1802.8068,"pbRate":"4.847322","latestPrice":1811.1105,"volume":90970843,"delay":0,"open":1825.6097,"prevYearClose":1637.1339,"prevWeekClose":1903.4879,"prevMonthClose":1862.664,"prevQuarterClose":1862.664,"fiveDayClose":1903.4879,"twentyDayClose":1915.5433,"sixtyDayClose":1751.8207,"secType":"PLATE","market":"US","turnoverRate":0.006557,"peRate":47.020292,"marketCap":1472930542925.5,"floatMarketCap":1437881726786,"timestamp":1790971199999,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":8,"down":10,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671829804","title":"Analysts Offer Insights on Healthcare Companies: Inventiva (IVA) and Moderna (MRNA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671829804","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671829804?lang=en_us&edition=fundamental","pubTime":"2026-09-29 13:00","pubTimestamp":1790658033,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Inventiva (IVA) and Moderna (MRNA). Inventiva (IVA...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-inventiva-iva-and-moderna-mrna-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-inventiva-iva-and-moderna-mrna-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","IDNA","MRNY","BK4551","LU0128526141.USD","WDNA","LU0029874061.USD","BK4139","BK4137","BK4534","MRNA","BK4581","MRNX","LGHT","BK4533","BK4585","HCSG","XLV","BK4588","BK4501","IVA","BK4548","BK4532","LABU","GNOM","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145285517","title":"Judge Rejects Pfizer, BioNTech, and Moderna Bid to Dismiss Monsanto mRNA Patent Lawsuit","url":"https://stock-news.laohu8.com/highlight/detail?id=1145285517","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145285517?lang=en_us&edition=fundamental","pubTime":"2026-09-29 10:39","pubTimestamp":1790649592,"startTime":"0","endTime":"0","summary":"A federal judge in Delaware rejected a request on Monday from Pfizer (PFE.US), BioNTech (BNTX.US), and Moderna (MRNA.US) to dismiss a lawsuit brought against them by Monsanto, a unit of German...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066051811.HKD","LU0738911758.USD","LU2896262040.SGD","SG9999013999.USD","LU1280957306.USD","LU0792757196.USD","LU0820561909.HKD","IE00BFTCPJ56.SGD","LU1732800096.USD","IE0002141913.USD","LU1074936037.SGD","MEDX","BK4559","IE00B7SZLL34.SGD","LU1032466523.USD","LU0345770308.USD","SG9999001176.SGD","IE0034235303.USD","LU0210536198.USD","LU0889566641.SGD","BK4504","LU2602419157.SGD","SG9999001440.SGD","IE00BVYPNV92.GBP","IE00BLSP4239.USD","IHE","FTXH","XLV","BK4548","GDOC","IE00B3T34201.USD","IYH","LU0225771236.USD","LU0320765646.SGD","LU0069063385.USD","FHLC","LU0456855351.SGD","VHT","LU0072461881.USD","LU0545562505.USD","BK4534","LU0868494617.USD","LU0943347566.SGD","LU1066051498.USD","IE00BJT1NW94.SGD","LU2112291526.USD","BK4599","LU2505996681.GBP","LU2023250330.USD","IE000BZT7R73.USD","MRNX","LU2468319806.SGD","LU0787776722.HKD","LU0882574055.USD","LGHT","LU0210528500.USD","LU1023059063.AUD","LU1061106388.HKD","LU1162221912.USD","BK4532","LU0162691827.USD","LU1506573853.SGD","LU0426412945.USD","LU1585245621.USD","LU2417539215.USD","LU0345770993.USD","IE00B19Z3581.USD","LU0466842654.USD","BK4139","BK4533","LU0225284248.USD","LU0661504455.SGD","LU0689472784.USD","SG9999002224.SGD","IE00B2B36J28.USD","IE00B42XCP33.USD","LU1674673428.USD","IE00BBT3K403.USD","LU0553294199.USD","IE00B1BXHZ80.USD","IE00BSNM7G36.USD","BK4007","LU0306807586.USD","LU0912757837.SGD","LU2596442595.SGD","LU0289739343.SGD","IE00BN8TJ469.HKD","LU1261432733.SGD","IE00BVYPNW00.USD","PFE","BK4592","LU1674673691.USD","LU1244550221.USD","IE00B3PB1722.GBP","LU2471134879.HKD","LU0234570918.USD","LU1228905540.USD","LU0098860793.USD","LU0345769631.USD","LU1267930813.SGD","LU0820561818.USD","LU0114720955.EUR","LU1121112475.USD","LU2756315318.SGD","BK4588","LU1894683348.USD","IE0001KFT4U8.USD","LU1929549753.HKD","LU1989771016.USD","GNOM","LU2471134952.CNY","LU0949170772.SGD","LU0289961442.SGD","LU1043141123.HKD","SGXZ80539844.SGD","LU2430703251.USD","LU1221951129.SGD","LU1066051225.USD","BNTX","LU1551013425.SGD","IE000F7OJYX1.SGD","IE00BJJMRZ35.SGD","LU1032955483.USD","LU0795875086.SGD","LU2430703178.SGD","IE0000B7K699.USD","LU2756315664.SGD","LU1935042991.SGD","LU2129689514.USD","BK4501","SG9999003800.SGD","RXL","LU0170899867.USD","LU0070217475.USD","LU2089984988.USD","LU2430703095.HKD","LU2592432038.USD","LU1066053197.SGD","LU0432979614.USD","LU1003077747.HKD","LU0985320562.USD","IE00B19Z3B42.SGD","LU0795875169.SGD","LU1629891620.HKD","LU1551013342.USD","LU2403377893.USD","LU1228905037.USD","LU2505996509.AUD","LU0345769128.USD","LU2750360641.GBP","LU0234572021.USD","BAYRY","MRNA","IE00BDGV0183.EUR","LU0689626769.HKD","IE00B4R5TH58.HKD","MRNY","IDNA","IE00BZ1G4Q59.USD","LU1057294990.SGD","BK4550","LU2129689431.USD","SGXZ57979304.SGD","LU0511384066.AUD","LU0964807845.USD","LU1430594728.SGD","LU0058720904.USD","LU2750360997.AUD","IE00BFXG1179.USD","LU0472753341.HKD","LU1244550494.USD","SG9999002232.USD","BK4585","IE0002270589.USD","LU0122379950.USD","LU1883839398.USD","LU1732799900.SGD","LU1244550577.SGD","LU2471134523.USD","JDOC","LU1894683264.USD","LU2487616109.SGD","LU0306806265.USD","LU1043141396.HKD","LU1059921491.USD","TRUH","LU0321505439.SGD","LU0683600562.USD","IE000SO60NU8.SGD","LU1196500208.SGD","BMED","LU2213496289.HKD","LU0321505868.SGD","BK4581","LU2456880835.USD","LU2347655156.SGD","LU1221951046.USD","LU0426417589.USD","PJP","LU0203347892.USD","LU2471134796.USD","LU0057025933.USD","LU0289739699.SGD","IE00BGHQF631.EUR","BK4568","IE000M9KFDE8.USD","LU0820562030.AUD","LU0124676726.USD","IE000WAW04H5.SGD","LU1145028129.USD","LU1914381329.SGD","BK4535","BK4551","LU1718418525.SGD","LU0203345920.USD","IE00BLSP4452.SGD","LU2236285917.USD","LU2129689605.HKD","LU1778281490.HKD","LU1983299246.USD","LU2133065610.SGD","SG9999001176.USD","SG9999011175.SGD","LU1496350502.SGD","LU1291159041.SGD","WDNA","IE00BKVL7J92.USD","LU0640476718.USD","OZEM","IE0009355771.USD","JNJ","IXJ","IE000MB6IJN5.SGD","LU0545039389.USD","LU0985481810.HKD","LU0994945656.USD","LU0053666078.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671086260","title":"How Investors May Respond To Pfizer (PFE) ESMO Cancer Data Showcase","url":"https://stock-news.laohu8.com/highlight/detail?id=2671086260","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671086260?lang=en_us&edition=fundamental","pubTime":"2026-09-29 09:19","pubTimestamp":1790644788,"startTime":"0","endTime":"0","summary":"Pfizer will showcase data from 45 oncology research abstracts at the October 2026 ESMO Congress in Madrid, including 11 oral presentations on established medicines such as PADCEV and TALZENNA, as well as late stage candidates like atirmociclib and tivunatamig.\nThe scale of Pfizer’s ESMO presence signals a strong R&D emphasis on cancer therapies at a time when the business is repositioning away from COVID products and facing pricing and competition pressure in other areas.\nWe will now look at...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/162270-card/1788974859487","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/162270-card/1788974859487"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-pfe/pfizer/news/how-investors-may-respond-to-pfizer-pfe-esmo-cancer-data-sho","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-pfe/pfizer/news/how-investors-may-respond-to-pfizer-pfe-esmo-cancer-data-sho","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0225284248.USD","LU1894683348.USD","SG9999003800.SGD","LU0225771236.USD","LU1057294990.SGD","SGXZ57979304.SGD","SG9999002224.SGD","SG9999011175.SGD","LU0321505868.SGD","LU0306807586.USD","LU0234572021.USD","BK4592","LU1066051498.USD","IE00BLSP4239.USD","SG9999001176.SGD","LU0122379950.USD","LU0985481810.HKD","LU1066053197.SGD","BK4007","LU0456855351.SGD","BK4588","IE00BLSP4452.SGD","LU0058720904.USD","LU0868494617.USD","LU1894683264.USD","IE0002270589.USD","IE00B19Z3B42.SGD","LU0289739699.SGD","LU0306806265.USD","LU0321505439.SGD","LU1023059063.AUD","LU2596442595.SGD","SG9999001176.USD","IE00B3T34201.USD","BK4550","LU1883839398.USD","BK4599","IE00BBT3K403.USD","BK4581","SG9999013999.USD","LU0170899867.USD","BK4585","PFE","BK4568","IE000M9KFDE8.USD","BK4534","OZEM","IE00B19Z3581.USD","SG9999002232.USD","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671666512","title":"Hutchmed says AstraZeneca submits NDA for ORPATHYS+TAGRISSO in NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2671666512","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671666512?lang=en_us&edition=fundamental","pubTime":"2026-09-29 08:06","pubTimestamp":1790640404,"startTime":"0","endTime":"0","summary":"Hutchmed (HCM) “announces that AstraZeneca (AZN) has submitted a New Drug Application to the US Food and Drug Administration for ORPATHYS (savoliti...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/hutchmed-says-astrazeneca-submits-nda-for-orpathystagrisso-in-nsclc-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/hutchmed-says-astrazeneca-submits-nda-for-orpathystagrisso-in-nsclc-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","BK4568","LU2237443978.SGD","LU2468319806.SGD","LU2237443622.USD","LU2237443895.HKD","AZNH","LU0128525929.USD","LU2236285917.USD","LU0310800379.SGD","BK4585","BK4588","LU2456880835.USD","LU0289739699.SGD","LU2237443465.HKD","HCM","BK4531","LU0708994859.HKD","BK4007","LU1829250122.USD","LU2237443549.SGD","LU0058720904.USD","LU0320765992.SGD","LU0432979614.USD","LU2237443382.USD","LU2462157665.USD","AZN","LU2417539215.USD","IE00B3T34201.USD","LU2089984988.USD","LU0109394709.USD","LU1267930573.SGD","LU0029864427.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671630272","title":"Stocks to Watch: Summit Therapeutics, Sangoma, Navitas","url":"https://stock-news.laohu8.com/highlight/detail?id=2671630272","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671630272?lang=en_us&edition=fundamental","pubTime":"2026-09-29 07:13","pubTimestamp":1790637180,"startTime":"0","endTime":"0","summary":"Summit Therapeutics is getting a $2 billion investment from AstraZeneca. The stock rose 17% to $18.08 in after-hours trading Monday.Sangoma Technologies is set to be acquired by BRC in a deal that values the company at $204 million. Shares climbed 39% to $4.98 after the bell.Navitas Semiconductor got an Army grant to develop semiconductor technology. The stock gained 14% to $13.40.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZN","SMMT","NVTS","BK4141","BK4588","LU2237443382.USD","LU2468319806.SGD","LU2237443895.HKD","LU0708994859.HKD","LU2237443549.SGD","AZNH","LU0320765992.SGD","BK4020","BK4007","LU2089984988.USD","LU2237443465.HKD","BK4139","LU2456880835.USD","LU2236285917.USD","LU0058720904.USD","BK4585","LU1829250122.USD","LU0889565916.HKD","LU1267930573.SGD","SANG","BK4568","NVTC","LU0432979614.USD","LU2237443978.SGD","LU2237443622.USD","LU0109394709.USD","LU2462157665.USD","LU0289739699.SGD","NVTX","LU2417539215.USD","LU0128525929.USD","LU2488822045.USD","LU0310800379.SGD","LU0029864427.USD","IE00B3T34201.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671268214","title":"Nanoviricides Q4 EPS $(0.10), Inline","url":"https://stock-news.laohu8.com/highlight/detail?id=2671268214","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671268214?lang=en_us&edition=fundamental","pubTime":"2026-09-29 05:47","pubTimestamp":1790632052,"startTime":"0","endTime":"0","summary":"Nanoviricides (AMEX:NNVC) reported quarterly losses of $(0.10) per share which met the analyst consensus estimate. This is a 23.08 percent increase over losses of $(0.13) per share from the same period last year.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/09/62037224/nanoviricides-q4-eps-0-10-inline","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Nanoviricides Q4 EPS $(0.10), Inline","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","NNVC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671680942","title":"Summit Therapeutics, AstraZeneca enter clinical collaboration agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2671680942","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671680942?lang=en_us&edition=fundamental","pubTime":"2026-09-29 05:40","pubTimestamp":1790631610,"startTime":"0","endTime":"0","summary":"Summit (SMMT) entered into a clinical collaboration agreement with AstraZeneca (AZN) to evaluate sonesitatug vedotin in combination with ivonescima...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/summit-therapeutics-astrazeneca-enter-clinical-collaboration-agreement-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/summit-therapeutics-astrazeneca-enter-clinical-collaboration-agreement-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AZNH","LU2237443382.USD","LU2488822045.USD","AZN","LU2456880835.USD","LU2237443622.USD","LU0320765992.SGD","LU0310800379.SGD","BK4568","LU2468319806.SGD","BK4007","LU1267930573.SGD","LU0109394709.USD","SMMT","LU2089984988.USD","LU0289739699.SGD","IE00B3T34201.USD","LU0128525929.USD","LU2237443895.HKD","LU0432979614.USD","BK4585","LU2237443978.SGD","LU2462157665.USD","LENZ","LU2237443549.SGD","LU0708994859.HKD","LU2236285917.USD","LU0029864427.USD","LU1829250122.USD","BK4139","LU0889565916.HKD","BK4539","LU2417539215.USD","BK4588","LU0058720904.USD","LU2237443465.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671268184","title":"Novavax Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2671268184","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671268184?lang=en_us&edition=fundamental","pubTime":"2026-09-29 05:30","pubTimestamp":1790631000,"startTime":"0","endTime":"0","summary":"DJ Novavax Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Novavax Inc.  rose 1.60% to $10.80 Monday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index  falling 0.92% to 26,820.38 and Dow Jones Industrial Average  falling 0.67% to 51,481.51.This was the stock's third consecutive day of gains.Novavax Inc. closed 9.77% below its 52-week high of $11.97, which the company reached on February 26th.The stock outperformed some of its competitors Monday, as Johnson & Johnson  rose 0.27% to $271.95, Pfizer Inc.  rose 0.17% to $28.72, and Merck & Co. Inc.  fell 0.06% to $148.69.Trading volume  remained 215,526 below its 50-day average volume of 4.7 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 28, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4547","BK4588","BK4139","NVAX","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671268309","title":"BioNTech CEO Uğur Şahin Disposes of USD 6,090,748 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2671268309","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671268309?lang=en_us&edition=fundamental","pubTime":"2026-09-29 05:17","pubTimestamp":1790630234,"startTime":"0","endTime":"0","summary":"BioNTech CEO Uur ahin disposes of USD 6,090,748 in common sharesBioNTech CEO Ugur Sahin sold 61,000 ordinary shares on Sept. 25-28, filings show.Sales priced at USD 98.6882 to USD 98.4682 per share.Di","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL8jQYft:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"BioNTech CEO Uğur Şahin Disposes of USD 6,090,748 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4535","BK4585","BK4568","BK4548","BK4588","BNTX","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671250558","title":"NanoViricides FY26 Net Loss Narrows 13% to $8.22 Million; Revenue Remains no Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2671250558","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671250558?lang=en_us&edition=fundamental","pubTime":"2026-09-29 04:32","pubTimestamp":1790627535,"startTime":"0","endTime":"0","summary":"NanoViricides FY26 net loss narrows 13% to $8.22 million; revenue remains no revenueNanoViricides posted a net loss of $8.22 million for the year ended June 30, 2026, narrowing 13%.Basic and diluted l","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL7KM1TX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","NNVC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671827252","title":"Pfizer, Moderna Lose Bids to Escape Bayer US mRNA Patent Lawsuit","url":"https://stock-news.laohu8.com/highlight/detail?id=2671827252","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671827252?lang=en_us&edition=fundamental","pubTime":"2026-09-29 02:20","pubTimestamp":1790619619,"startTime":"0","endTime":"0","summary":"Pfizer, Moderna lose bids to escape Bayer US mRNA patent lawsuitSept 28 (Reuters)-A federal judge in Delaware on Monday rejected PfizerPFE.N, BioNTech22UAy.DEand Moderna'sMRNA.Orequests to dismiss pat","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nL6N45K0Z5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0868494617.USD","BK4501","LU0225284248.USD","LU1057294990.SGD","BK4588","BK4581","GNOM","IE00BBT3K403.USD","MRNY","BK4139","SGXZ57979304.SGD","IE000M9KFDE8.USD","BK4599","BNTX","BK4535","IE00B19Z3581.USD","SG9999003800.SGD","WDNA","LGHT","LU0170899867.USD","SG9999001176.SGD","LU1894683348.USD","IE00BLSP4452.SGD","SG9999002232.USD","IE0002270589.USD","BK4585","LU1894683264.USD","LU0321505868.SGD","LU0985481810.HKD","BK4533","BK4568","IE00B19Z3B42.SGD","BK4551","LU0321505439.SGD","LU1066051498.USD","MRNX","BAYZF","LU2596442595.SGD","BK4007","SG9999001176.USD","BK4534","MRNA","BK4550","LU0289739699.SGD","LU0225771236.USD","LU1883839398.USD","PFE","BK4592","LU1023059063.AUD","SG9999002224.SGD","LU0122379950.USD","LU0456855351.SGD","LU1066053197.SGD","IE00B3T34201.USD","SG9999013999.USD","LU0058720904.USD","BK4532","SG9999011175.SGD","BK4548","LU0306807586.USD","OZEM","IDNA","LU0306806265.USD","IE00BLSP4239.USD","LU0234572021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671504251","title":"Market Chatter: BioNTech to Close 3 German Sites After Unsuccessful Sale Efforts","url":"https://stock-news.laohu8.com/highlight/detail?id=2671504251","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671504251?lang=en_us&edition=fundamental","pubTime":"2026-09-29 00:42","pubTimestamp":1790613721,"startTime":"0","endTime":"0","summary":"BioNTech  is closing three German sites it failed to sell in a shift away from pandemic-era manufacturing, Reuters reported Monday, citing a company spokesperson.The company agreed with the works council on socially responsible solutions and supplementary redundancy for affected employees, the report said.BioNTech did not immediately respond to a request for comment from MT Newswires.Price: 99.12, Change: +0.60, Percent Change: +0.61","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4585","BK4588","BK4548","BK4568","BK4551","BK4535","BNTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671251560","title":"AstraZeneca Advances Fixed-Dose Cholesterol Combo With Completed Phase I Bioavailability Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2671251560","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671251560?lang=en_us&edition=fundamental","pubTime":"2026-09-29 00:30","pubTimestamp":1790613011,"startTime":"0","endTime":"0","summary":"AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. AstraZeneca (AZN) has completed a Phase I study titled “A Phase I, R...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/astrazeneca-advances-fixed-dose-cholesterol-combo-with-completed-phase-i-bioavailability-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/astrazeneca-advances-fixed-dose-cholesterol-combo-with-completed-phase-i-bioavailability-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0109394709.USD","LU1829250122.USD","LU0320765992.SGD","LU0029864427.USD","LU0432979614.USD","LU1267930573.SGD","LU2417539215.USD","LU0889565916.HKD","LU2456880835.USD","BK4007","LU2236285917.USD","LU2468319806.SGD","LU2462157665.USD","BK4585","AZNH","LU2237443382.USD","LU0128525929.USD","LU0708994859.HKD","LU2237443895.HKD","LU2237443549.SGD","LU0310800379.SGD","IE00B3T34201.USD","AZN","LU0058720904.USD","LU2237443978.SGD","BK4588","LU2237443622.USD","LU0289739699.SGD","LU2089984988.USD","LU2237443465.HKD","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671596092","title":"AstraZeneca PLC Stock Rises Monday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2671596092","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671596092?lang=en_us&edition=fundamental","pubTime":"2026-09-29 00:01","pubTimestamp":1790611260,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of AstraZeneca PLC rose 0.6% to SEK1,650.50 Monday on what proved to be an overall poor trading session for the stock market, with the OMX Nordic 40 Index falling 0.6% to 2,608.33.This was the stock's second consecutive day of gains.The company closed SEK275.00 below its 52-week high of SEK1,925.50, which the company reached on April 10, 2026.Trading volume was 535,612, compared to the 50-day average trading volume of 615,757.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1829250122.USD","LU2237443895.HKD","LU2468319806.SGD","LU0310800379.SGD","LU2237443382.USD","AZNH","BK4585","LU2462157665.USD","LU0320765992.SGD","LU2236285917.USD","LU2237443978.SGD","LU0889565916.HKD","LU0432979614.USD","LU2237443622.USD","LU2089984988.USD","LU2237443465.HKD","AZN","LU2237443549.SGD","LU2456880835.USD","IE00B3T34201.USD","LU0128525929.USD","LU2417539215.USD","LU0058720904.USD","BK4588","LU0109394709.USD","BK4568","LU0289739699.SGD","BK4007","LU0029864427.USD","LU1267930573.SGD","LU0708994859.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670259374","title":"Pfizer's Tilrekimig Phase 3 Program Seen as Potential Upside Driver, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2670259374","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670259374?lang=en_us&edition=fundamental","pubTime":"2026-09-28 23:52","pubTimestamp":1790610732,"startTime":"0","endTime":"0","summary":"Pfizer's  new phase 3 studies of tilrekimig in atopic dermatitis and asthma may drive upside if results are positive, UBS Securities said Friday in a report.The adult atopic-dermatitis study will be run head-to-head against Dupixent, which is developed jointly by Sanofi  and Regeneron Pharmaceuticals , and UBS said the potential commercial contribution is not yet reflected in consensus estimates.Topline data released in March showed competitive placebo-adjusted EASI-75 rates of about 50% at the middle and high doses, and UBS said Pfizer is likely working to maximize efficacy at the middle-dose level.UBS maintained its neutral rating on Pfizer stock with a $27 price target.Price: 28.59, Change: -0.09, Percent Change: -0.30","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1057294990.SGD","LU1883839398.USD","SGXZ57979304.SGD","SG9999011175.SGD","IE00B19Z3581.USD","LU0456855351.SGD","SG9999013999.USD","LU0122379950.USD","BK4599","LU1894683264.USD","BK4585","LU1066051498.USD","LU0321505868.SGD","LU2596442595.SGD","BK4588","BK4007","LU0321505439.SGD","BK4533","IE00B3T34201.USD","BK4581","IE00BLSP4452.SGD","LU0234572021.USD","BK4592","SG9999001176.SGD","SG9999003800.SGD","LU0868494617.USD","LU0306807586.USD","LU0225771236.USD","LU0306806265.USD","LU0985481810.HKD","BK4568","PFE","BK4534","OZEM","SG9999002232.USD","IE00BLSP4239.USD","LU0170899867.USD","LU1894683348.USD","LU1066053197.SGD","SG9999002224.SGD","BK4550","IE00B19Z3B42.SGD","LU0289739699.SGD","IE00BBT3K403.USD","LU0225284248.USD","LU1023059063.AUD","IE0002270589.USD","SG9999001176.USD","LU0058720904.USD","IE000M9KFDE8.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670125563","title":"BioNTech to Proceed with Site Closures After Failing to Find Buyer","url":"https://stock-news.laohu8.com/highlight/detail?id=2670125563","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670125563?lang=en_us&edition=fundamental","pubTime":"2026-09-28 22:35","pubTimestamp":1790606100,"startTime":"0","endTime":"0","summary":"BioNTech said it would proceed with the closure of sites after it couldn't reach agreements to sell the facilities.\"Despite the intensive efforts of all parties involved and a broad-based sales process, it was unfortunately not possible to realize a sale,\" the company said Monday.In May, BioNTech said it would exit its Idar-Oberstein and Marburg sites in Germany, as well as its operations in Singapore and other facilities owned by CureVac before its acquisition, but that it would explore options for a partial or total sale for each. The company said at the time it expected the decision to affect up to 1,860 positions in total.The company said in August that a fund advised by Dubag Group would acquire its JPT Peptide Technologies subsidiary to ensure the business's continuity.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","BNTX","BK4139","BK4551","BK4588","BK4585","BK4535","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670255552","title":"US Drugmakers Turn to China for Licensing Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=2670255552","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670255552?lang=en_us&edition=fundamental","pubTime":"2026-09-28 22:31","pubTimestamp":1790605880,"startTime":"0","endTime":"0","summary":"FACTBOX-US drugmakers turn to China for licensing dealsSept 28 (Reuters)-MerckMRK.Non Monday agreed to payChinese biotechSciBrunch Therapeutics $400 million upfront for global rights to an experimenta","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nL4N45K0UD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2097828557.USD","LU0211328371.USD","LU0225284248.USD","SG9999001176.USD","LU2129689605.HKD","LU2602419157.SGD","IHE","LU1699723380.USD","LU2468319806.SGD","LU0306807586.USD","IE000BZT7R73.USD","LU0058720904.USD","WDNA","KURE","LU1868836914.USD","LU0661504455.SGD","MEDI","IE00BDGV0183.EUR","SG9999015986.USD","LU0456855351.SGD","LU1988902786.USD","BK4599","ILDR","ELIS","LU2471134879.HKD","SGXZ31699556.SGD","LU1188198961.HKD","LU2491050071.SGD","TMED","LU1732800096.USD","LU0320765646.SGD","LU0965509283.SGD","LU1941712264.USD","SG9999014898.SGD","LU1127390331.HKD","SG9999002224.SGD","LU0795875086.SGD","SG9999015952.SGD","LU0882574055.USD","LU0320765992.SGD","LU0985320562.USD","LU0861579265.USD","LU1585245621.USD","LU2106854487.HKD","LU0823434583.USD","LU1868837300.USD","IE00B4JS1V06.HKD","LU0174119429.USD","LU2488822045.USD","BK4585","IE00BN29S564.USD","LU1244550221.USD","LU2023251221.USD","LLYZ","IE00B1BXHZ80.USD","IE00BLSP4239.USD","LU0463099449.HKD","LU1093756168.USD","IE00BLSP4452.SGD","LU0326950275.SGD","LU0079474960.USD","LU0472753341.HKD","SG9999013999.USD","IE00BK4W5L77.USD","LU1732799900.SGD","LU2896262040.SGD","LU0162691827.USD","LU2461242641.AUD","LU1023059063.AUD","LU0455707207.USD","SG9999014906.USD","SG9999002232.USD","IE000SO60NU8.SGD","LU0980610538.SGD","IE00BFTCPJ56.SGD","IE00B1XK9C88.USD","LU0432979614.USD","LU0109394709.USD","LU1831875114.USD","LU2125154935.USD","FHLC","LU0310799852.SGD","01801","IE00BVYPNW00.USD","LU0234572021.USD","MRK","SG9999014559.SGD","SG9999017495.SGD","IE000M9KFDE8.USD","BK4532","LU1989772840.SGD","LU1366192091.USD","LU0882574139.USD","IE00BKDWB100.SGD","LU2211815571.USD","SG9999014914.USD","LU1868836591.USD","LU1267930730.SGD","LU1989772923.USD","LU2433249047.HKD","LU0203201768.USD","LU1267930573.SGD","LU0106261372.USD","LU1057294990.SGD","LU1670627923.USD","SG9999015945.SGD","IYH","LU0006306889.USD","IE00BSNM7G36.USD","SG9999014567.USD","BK4533","LU2456880835.USD","TBXU","LU0965509101.SGD","LU0471298694.HKD","SG9999001440.SGD","LU2552382215.SGD","LU2087621335.USD","LU2213496289.HKD","LU2237443622.USD","LU0859254822.USD","LU0672654240.SGD","LU2491049909.HKD","SG9999014542.SGD","LU0124676726.USD","BK4534","IBB","LU2111349929.HKD","LU1244550577.SGD","LU1291159041.SGD","LU2362540622.SGD","LU2168564065.EUR","PPH","XLV","REGN","LU0289961442.SGD","LU1670711040.USD","BK4581","CANC","LU2023250330.USD","IE00BFSS8Q28.SGD","LU0985481810.HKD","LU0266013472.USD","LU0820561909.HKD","IE0004445015.USD","LU0965508806.USD","BK4568","LU2125154778.USD","LU1066051498.USD","LU2462591350.SGD","LU0345770308.USD","LU1232071149.USD","SG9999003800.SGD","LU2125909247.SGD","LU1201861249.SGD","LU0237698245.USD","SGXZ57979304.SGD","LU2596442595.SGD","IE0000B7K699.USD","LU0225771236.USD","LU0354030438.USD","BK4139","LU1691799644.USD","BK4588","LU0943347566.SGD","GDOC","LU0942090050.USD","LU2361044865.SGD","LU2347655073.USD","LU1267930490.SGD","LU0029864427.USD","IE0009355771.USD","LU2471134523.USD","IE00BKPKM429.USD","LU2271345857.HKD","LU1923622614.USD","HK0000165453.HKD","LU0094547139.USD","LU0964807845.USD","SG9999014575.USD","IE0005OL40V9.USD","LU0868494617.USD","BK4007","LU2168564495.EUR","IE00BJT1NW94.SGD","SGXZ51526630.SGD","LU2417539215.USD","LU1917777945.USD","LU1839511570.USD","LU0225283273.USD","LU0122379950.USD","LU1974910355.USD","BK4559","HRTS","LU2324357040.USD","IE0004445239.USD","LU1969619763.USD","LU0795875169.SGD","LU0149534421.HKD","LU0502904849.HKD","LU1066051811.HKD","PAWZ","LU0072461881.USD","LU0203202063.USD","LU0965509010.AUD","SG9999018865.SGD","IE00BGHQF631.EUR","LU2087625088.SGD","LU1280957306.USD","LU2746668974.SGD","LU1032466523.USD","LU2756315318.SGD","IE00B19Z3B42.SGD","THNR","LU1934455863.HKD","LU0061475181.USD","LU1868836757.USD","LU2750360997.AUD","LU0466842654.USD","LU0786609619.USD","LU0198837287.USD","LU1894683348.USD","LU1162221912.USD","LU0353189680.USD","ABBV","LU0238689110.USD","BK4566","LU0158827948.USD","LU0820561818.USD","LU2552382132.HKD","SGXZ99366536.SGD","LU2362541273.HKD","LU1629891620.HKD","LU1064131342.USD","LU0210536198.USD","LU1720051108.HKD","LU0057025933.USD","LLY","LU0689626769.HKD","OZEM","BMED","LU0070302665.USD","LU2360106947.USD","LU1116320901.HKD","IE00B42XCP33.USD","LU2089984988.USD","IE00B7KXQ091.USD","LU2097828474.EUR","LU0726765562.USD","LU1037948541.HKD","IE00B19Z3581.USD","LU1035775433.USD","LU0823434740.USD","LU2237438978.USD","LU1236620750.USD","IXJ","LU1894683264.USD","LU2023250504.SGD","LU1571399168.USD","LU1066053197.SGD","LU0321505868.SGD","LU1934455194.USD","LU1037948897.HKD","LU1069344957.HKD","SG9999015978.USD","LU2028103732.USD","LU0211331839.USD","LU0553294199.USD","LU2063271972.USD","IE000WAW04H5.SGD","LU0256863811.USD","LU0477156953.USD","LU2242646821.SGD","BK4592","LU0354030511.USD","LU2462157665.USD","LU0096364046.USD","LU2237443382.USD","LU0053666078.USD","LU0417517546.SGD","LU2097828714.EUR","LU2108987350.USD","IE0002141913.USD","LU0265550946.USD","CURE","LU1061106388.HKD","LU1670711123.USD","LU0320765489.SGD","LU2237443549.SGD","LU0738911758.USD","PJP","LU1496350502.SGD","LU0820562030.AUD","LU0640476718.USD","LU2237443895.HKD","IE00B3PB1722.GBP","LU0267386448.USD","LU0109391861.USD","LU2491050154.USD","LU2347655156.SGD","LU2097828631.EUR","LU1670710588.SGD","LU0234570918.USD","LU1261432733.SGD","LU2089284900.SGD","LU1496350171.SGD","LU1074936037.SGD","LU2125909593.SGD","BK1583","AGNG","LU2265009873.SGD","LU1670710661.SGD","LU2746668461.USD","LU2237443465.HKD","JDOC","LU1548497426.USD","IE00BJJMRZ35.SGD","LU1623119135.USD","LU2360032135.SGD","LU2236285917.USD","LU0345770993.USD","LU2168564149.EUR","LU2361044949.HKD","LU2237443978.SGD","LU0130517989.USD","LU1941712348.USD","LU0708994859.HKD","SGXZ81514606.USD","BMY","LU0912757837.SGD","VHT","IE00B2B36J28.USD","LU0868494708.USD","LU1712237335.SGD","LU1670628061.USD","LU0289739699.SGD","LU2552382058.USD","IE00BK4W5M84.HKD","LU0949170772.SGD","LU1868837136.USD","LU0823416689.USD","LU0289739343.SGD","LU1883839398.USD","IE0001KFT4U8.USD","LU0321505439.SGD","LU0889565916.HKD","LU1979441026.SGD","LU0471298777.SGD","BK1161","LU0787776722.HKD","LU2242652126.USD","LU1236620834.HKD","SG9999015358.SGD","LU1718418525.SGD","IE00BJJMRY28.SGD","IE00B4R5TH58.HKD","LU0320765059.SGD","BBH","LU0395794307.EUR","LU0511384066.AUD","GB00BDT5M118.USD","LU2133065610.SGD","LU1804176565.USD","IE00BFXG1179.USD","LU1983299246.USD","LU0689472784.USD","LU2750360641.GBP","LU0323591593.USD","LU0128525929.USD","FTXH","IE00BJLML261.HKD","LU0683600562.USD","LU0114720955.EUR","LU0133085943.USD","LU2361045086.USD","LU2756315664.SGD","SG9999011175.SGD","LU0708995401.HKD","LU1551013425.SGD","LU0211327993.USD","BK4516","LU1720051017.SGD","BK4550","LU2112291526.USD","LU2362541513.USD","LU2168563687.JPY","LU1069347547.HKD","LU0170899867.USD","LU0545039389.USD","IE00B3T34201.USD","LU2264538146.SGD","SG9999018857.SGD","SG9999001176.SGD","LU1093756325.SGD","LU0208291251.USD","LU2097828805.USD","LU2168564222.USD","LU0256863902.USD","LU0098860793.USD","IE00B775H168.HKD","LU2328871848.SGD","SG9999015341.SGD","IE00BJJMRX11.SGD","LU2471134796.USD","LU1551013342.USD","LU2357305700.SGD","GLAM","LU1244550494.USD","LU1145028129.USD","IE00BN8TJ469.HKD","IE00BWXC8680.SGD","LU2023250843.SGD","LU2357627491.SGD","LU0130102774.USD","LU0265550359.USD","LU0316494557.USD","IE00BBT3K403.USD","RXL","LLYX","LU1066051225.USD","LU0353189763.USD","LU1934455277.USD","LU2129689431.USD","LU0385154629.USD","LU0306806265.USD","IBBQ","LU1003077747.HKD","LU1116320737.USD","LU0244354667.USD","IE000MB6IJN5.SGD","LU0203347892.USD","LU0097036916.USD","LU2129689514.USD","MEDX","LU0203345920.USD","BK1589","LU0648001328.SGD","IE00BFSS7M15.SGD","LU2242644610.SGD","LU2471134952.CNY","LU0069063385.USD","ELIL","SG9999014880.SGD","IE0002270589.USD","TRUH","IE000F7OJYX1.SGD","LU1430594728.SGD","LU0607220059.USD","LU2089283258.USD","LU1323610961.USD","IE00BVYPNV92.GBP","LU0158827781.USD","LU1929549753.HKD","LU1989771016.USD","LLII","LU1814569148.SGD","PFE","MHIP","LU1035773651.USD","LU0310800379.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670237478","title":"NanoViricides Starts Phase II DRC Trial of Oral NV-387 Gummies in Bundibugyo Ebola Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2670237478","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670237478?lang=en_us&edition=fundamental","pubTime":"2026-09-28 20:45","pubTimestamp":1790599532,"startTime":"0","endTime":"0","summary":"NanoViricides starts Phase II DRC trial of oral NV-387 gummies in Bundibugyo Ebola patientsNanoViricides began enrolling and dosing patients in a Phase II trial of NV-387 oral gummies for Ebola in the","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL2v5BJN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NNVC","BK4568","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670423256","title":"Humacyte Adds Scott Coward to Board, Names Him to Audit Committee","url":"https://stock-news.laohu8.com/highlight/detail?id=2670423256","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670423256?lang=en_us&edition=fundamental","pubTime":"2026-09-28 20:03","pubTimestamp":1790596983,"startTime":"0","endTime":"0","summary":"Humacyte adds Scott Coward to board, names him to audit committeeHumacyte added Scott Coward and Paul Kuznik to its board as it expands the Symvess launch and prepares an ATEV dialysis-access launch.C","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL2fwfyJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IHI","LU1721429741.USD","LU0122379950.USD","LU0211331839.USD","LU2133065610.SGD","LU0320765489.SGD","LU2237957902.USD","HUMA","TMED","BK4568","LU2468319806.SGD","LU1023059063.AUD","LU0266013472.USD","IE00BN0W2V16.EUR","LU0208291251.USD","ABT","IE00BQXX3C00.GBP","SG9999014021.USD","IE00BN0W2W23.USD","LU1057294990.SGD","BK4566","PJP","IE0009355771.USD","LU2095319765.USD","NDAQ","SG9999002224.SGD","LU1989763690.USD","LU0314104364.USD","BK4112","IE00B2B36J28.USD","BK4585","LU0170899867.USD","LU1983299246.USD","IE00BKPKM429.USD","SG9999002232.USD","BCDF","LU2210150020.SGD","SG9999004303.SGD","IE00B3QW5Z07.USD","SGXZ41872573.SGD","IE0002141913.USD","LU2237957811.SGD","LU1670628061.USD","IE00B64PRP62.GBP","SG9999014005.SGD","LU0070302665.USD","BK4588","LU0058720904.USD","BK4082","IE00BQXX3F31.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670019231","title":"Xilio Therapeutics Names Yariv Houvras Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2670019231","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670019231?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:30","pubTimestamp":1790595055,"startTime":"0","endTime":"0","summary":"Xilio Therapeutics names Yariv Houvras chief medical officerXilio Therapeutics named Yariv J. Houvras chief medical officer on Sept. 28, 2026.He previously led clinical and translational development a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL8GCH5H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","IE00B3T34201.USD","LU1066053197.SGD","LU1934455863.HKD","BMED","IE00BN0W2W23.USD","SG9999014013.SGD","LU0823416689.USD","MEDI","LU0859254822.USD","LU2468319806.SGD","NDAQ","LU0965509101.SGD","SG9999015952.SGD","LU2087621335.USD","LU1839511570.USD","IE00BN0W2V16.EUR","SG9999015978.USD","IE00B19Z3B42.SGD","LU1430594728.SGD","LU2112291526.USD","SG9999014021.USD","TMED","IE00BKPKM429.USD","LU1061106388.HKD","BCDF","BK4568","IE00BQXX3C00.GBP","LU1571399168.USD","BK4583","GILD","LU2210150020.SGD","LU1066051498.USD","LU2210149790.SGD","LU0861579265.USD","LU1934455277.USD","XLO","LU0234570918.USD","IE00B19Z3581.USD","BK4532","BBH","LU2089984988.USD","IBBQ","IE00BKVL7J92.USD","LU1037948897.HKD","LU0965509283.SGD","BK4566","IBB","TBXU","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":12,"pageCount":7,"totalSize":235,"code":"91000000","status":"200"}]}}